ProCE Banner Activity

Slides From Targeted Therapies for Migraine Prevention in the Challenging Migraineur: Focus on CGRP Blockade

Slideset Download
Review expert insights into the latest efficacy and safety data on established and investigational CGRP-targeting agents, including monoclonal antibodies, gepants, ditans, and triptans.

Released: February 14, 2020

Expiration: February 12, 2021

No longer available for credit.
Begin Activity

Share

Faculty

Wade Cooper

Wade Cooper, DO

Director, Headache and Neuropathic Pain
Clinical Associate Professor, Neurology and Anesthesiology
University of Michigan
Ann Arbor, Michigan

Merle Diamond

Merle Diamond, MD

Clinical Assistant Professor
Department of Medicine
Rosalind Franklin University
President
Managing Director

Diamond Headache Clinic
AMITA Health St Joseph Hospital
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Lundbeck

Faculty Disclosure

Primary Author

Wade Cooper, DO

Director, Headache and Neuropathic Pain
Clinical Associate Professor, Neurology and Anesthesiology
University of Michigan
Ann Arbor, Michigan

Merle Diamond, MD

Clinical Assistant Professor
Department of Medicine
Rosalind Franklin University
President
Managing Director

Diamond Headache Clinic
AMITA Health St Joseph Hospital
Chicago, Illinois